Twenty-First Century Pathology Sign-Out

被引：2

作者：

Tomlins, Scott ^{[1
]}

Robinson, Daniel ^{[1
]}

Penny, Robert J. ^{[2
]}

Hess, Jay L.

机构：

[1] Univ Michigan, Sch Med, Dept Pathol, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA

[2] Int Genom Consortium, Phoenix, AZ 85004 USA

来源：

CLINICS IN LABORATORY MEDICINE | 2012年 / 32卷 / 04期

关键词：

Personalized medicine; Molecular diagnostics; Future of pathology; PROSTATE-CANCER; US;

D O I：

10.1016/j.cll.2012.07.002

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

It is difficult to imagine a field that is changing as rapidly as pathology. A convergence of factors including not only scientific and technological advances but also changes in business models is transforming the field, particularly in the area of cancer diagnostics. The authors examine 8 themes, or "forces of change," in pathology and speculate on how these will affect pathology sign-out and the future role of pathologists in patient care.

引用

页码：639 / +

页数：13

共 25 条

[1] Utilizing circulating tumor cells: challenges and pitfalls
Attard, Gerhardt
de Bono, Johann S.
[J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (01) : 50 - 58
[2] Antitumor Activity with CYP17 Blockade Indicates That Castration-Resistant Prostate Cancer Frequently Remains Hormone Driven
Attard, Gerhardt
Reid, Alison H. M.
Olmos, David
de Bono, Johann S.
[J]. CANCER RESEARCH, 2009, 69 (12) : 4937 - 4940
[3] What's Keeping Us So Busy in Primary Care? A Snapshot from One Practice
Baron, Richard J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) : 1632 - 1636
[4] The genomic complexity of primary human prostate cancer
Berger, Michael F.
Lawrence, Michael S.
Demichelis, Francesca
Drier, Yotam
Cibulskis, Kristian
Sivachenko, Andrey Y.
Sboner, Andrea
Esgueva, Raquel
Pflueger, Dorothee
Sougnez, Carrie
Onofrio, Robert
Carter, Scott L.
Park, Kyung
Habegger, Lukas
Ambrogio, Lauren
Fennell, Timothy
Parkin, Melissa
Saksena, Gordon
Voet, Douglas
Ramos, Alex H.
Pugh, Trevor J.
Wilkinson, Jane
Fisher, Sheila
Winckler, Wendy
Mahan, Scott
Ardlie, Kristin
Baldwin, Jennifer
Simons, Jonathan W.
Kitabayashi, Naoki
MacDonald, Theresa Y.
Kantoff, Philip W.
Chin, Lynda
Gabriel, Stacey B.
Gerstein, Mark B.
Golub, Todd R.
Meyerson, Matthew
Tewari, Ashutosh
Lander, Eric S.
Getz, Gad
Rubin, Mark A.
Garraway, Levi A.
[J]. NATURE, 2011, 470 (7333) : 214 - 220
[5] Functional Viability Profiles of Breast Cancer
Brough, Rachel
Frankum, Jessica R.
Sims, David
Mackay, Alan
Mendes-Pereira, Ana M.
Bajrami, Ilirjana
Costa-Cabral, Sara
Rafiq, Rumana
Ahmad, Amar S.
Cerone, Maria Antonietta
Natrajan, Rachael
Sharpe, Rachel
Shiu, Kai-Keen
Wetterskog, Daniel
Dedes, Konstantine J.
Lambros, Maryou B.
Rawjee, Teeara
Linardopoulos, Spiros
Reis-Filho, Jorge S.
Turner, Nicholas C.
Lord, Christopher J.
Ashworth, Alan
[J]. CANCER DISCOVERY, 2011, 1 (03) : 260 - 273
[6] Medullary Thyroid Cancer: Molecular Biology and Novel Molecular Therapies
Cakir, Mehtap
Grossman, Ashley B.
[J]. NEUROENDOCRINOLOGY, 2009, 90 (04) : 323 - 348
[7] Systematic investigation of genetic vulnerabilities across cancer cell lines reveals lineage-specific dependencies in ovarian cancer
Cheung, Hiu Wing
Cowley, Glenn S.
Weir, Barbara A.
Boehm, Jesse S.
Rusin, Scott
Scott, Justine A.
East, Alexandra
Ali, Levi D.
Lizotte, Patrick H.
Wong, Terence C.
Jiang, Guozhi
Hsiao, Jessica
Mermel, Craig H.
Getz, Gad
Barretina, Jordi
Gopal, Shuba
Tamayo, Pablo
Gould, Joshua
Tsherniak, Aviad
Stransky, Nicolas
Luo, Biao
Ren, Yin
Drapkin, Ronny
Bhatia, Sangeeta N.
Mesirov, Jill P.
Garraway, Levi A.
Meyerson, Matthew
Lander, Eric S.
Root, David E.
Hahn, William C.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (30) : 12372 - 12377
[8] Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Fong, Peter C.
Boss, David S.
Yap, Timothy A.
Tutt, Andrew
Wu, Peijun
Mergui-Roelvink, Marja
Mortimer, Peter
Swaisland, Helen
Lau, Alan
O'Connor, Mark J.
Ashworth, Alan
Carmichael, James
Kaye, Stan B.
Schellens, Jan H. M.
de Bono, Johann S.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (02) : 123 - 134
[9] Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, Mathew J.
Edelman, Elena J.
Heidorn, Sonja J.
Greenman, Chris D.
Dastur, Anahita
Lau, King Wai
Greninger, Patricia
Thompson, I. Richard
Luo, Xi
Soares, Jorge
Liu, Qingsong
Iorio, Francesco
Surdez, Didier
Chen, Li
Milano, Randy J.
Bignell, Graham R.
Tam, Ah T.
Davies, Helen
Stevenson, Jesse A.
Barthorpe, Syd
Lutz, Stephen R.
Kogera, Fiona
Lawrence, Karl
McLaren-Douglas, Anne
Mitropoulos, Xeni
Mironenko, Tatiana
Thi, Helen
Richardson, Laura
Zhou, Wenjun
Jewitt, Frances
Zhang, Tinghu
O'Brien, Patrick
Boisvert, Jessica L.
Price, Stacey
Hur, Wooyoung
Yang, Wanjuan
Deng, Xianming
Butler, Adam
Choi, Hwan Geun
Chang, JaeWon
Baselga, Jose
Stamenkovic, Ivan
Engelman, Jeffrey A.
Sharma, Sreenath V.
Delattre, Olivier
Saez-Rodriguez, Julio
Gray, Nathanael S.
Settleman, Jeffrey
Futreal, P. Andrew
Haber, Daniel A.
[J]. NATURE, 2012, 483 (7391) : 570 - U87
[10] Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, Marco
Rowan, Andrew J.
Horswell, Stuart
Larkin, James
Endesfelder, David
Gronroos, Eva
Martinez, Pierre
Matthews, Nicholas
Stewart, Aengus
Tarpey, Patrick
Varela, Ignacio
Phillimore, Benjamin
Begum, Sharmin
McDonald, Neil Q.
Butler, Adam
Jones, David
Raine, Keiran
Latimer, Calli
Santos, Claudio R.
Nohadani, Mahrokh
Eklund, Aron C.
Spencer-Dene, Bradley
Clark, Graham
Pickering, Lisa
Stamp, Gordon
Gore, Martin
Szallasi, Zoltan
Downward, Julian
Futreal, P. Andrew
Swanton, Charles
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) : 883 - 892

← 1 2 3 →